aluates Reports

$ 0.0

Automative

Global Hemoglobinopathies Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-16W6032

Global Hemoglobinopathies Market Insights and Forecast to 2028

BUY CHAPTERS

Global Hemoglobinopathies Market Insights, Forecast to 2030

Code: QYRE-Auto-16W6032

Report

December 2024

Pages:93

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Gamida Cell

Alnylam Pharmaceuticals

Sanofi

Sangamo Therapeutics, Inc.

Global Blood Therapeutics

Bluebird bio

Emmaus Life Sciences, Inc.

Prolong Pharmaceuticals

Celgene Corporation

Hemoglobinopathies Market Size

The global Hemoglobinopathies market is projected to grow from US$ 295.4 million in 2024 to US$ 384.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period.

Hemoglobinopathies Market

Hemoglobinopathy or Hemoglobinopathies is the medical term for a group of blood disorders and diseases that affect red blood cells. It can be a kind of genetic defect that results in abnormal structure of one of the globin chains of the hemoglobin molecule.

Market Analysis and Insights: Global Hemoglobinopathies Market

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Covers:

This report presents an overview of global market for Hemoglobinopathies market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Hemoglobinopathies, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Hemoglobinopathies, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hemoglobinopathies revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Hemoglobinopathies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Hemoglobinopathies revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Hemoglobinopathies Market Report

Report Metric	Details
Report Name	Hemoglobinopathies Market
Accounted market size in 2024	US$ 295.4 million
Forecasted market size in 2030	US$ 384.7 million
CAGR	4.5
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Blood Transfusion Iron Chelation Therapy Bone Marrow Transplant Others
Segment by Application	Blood Testing Genetic Testing Pre-Implantation Genetic Diagnosis (PGD) Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Gamida Cell, Alnylam Pharmaceuticals, Sanofi, Sangamo Therapeutics Inc., Global Blood Therapeutics, Bluebird Bio, Emmaus Life Sciences Inc., Prolong Pharmaceuticals, Celgene Corporation
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Hemoglobinopathies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemoglobinopathies companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hemoglobinopathies revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Hemoglobinopathies Market growing?

Ans: The Hemoglobinopathies Market witnessing a CAGR of 4.5 during the forecast period 2025-2030.

What is the Hemoglobinopathies Market size in 2030?

Ans: The Hemoglobinopathies Market size in 2030 will be US$ 384.7 million.

Who are the main players in the Hemoglobinopathies Market report?

Ans: The main players in the Hemoglobinopathies Market are Gamida Cell, Alnylam Pharmaceuticals, Sanofi, Sangamo Therapeutics Inc., Global Blood Therapeutics, Bluebird Bio, Emmaus Life Sciences Inc., Prolong Pharmaceuticals, Celgene Corporation

What are the Application segmentation covered in the Hemoglobinopathies Market report?

Ans: The Applications covered in the Hemoglobinopathies Market report are Blood Testing, Genetic Testing, Pre-Implantation Genetic Diagnosis (PGD), Others

What are the Type segmentation covered in the Hemoglobinopathies Market report?

Ans: The Types covered in the Hemoglobinopathies Market report are Blood Transfusion, Iron Chelation Therapy, Bone Marrow Transplant, Others

Recommended Reports

Hemoglobinopathy Diagnostics

Hematology Analyzers

Blood Related Devices

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hemoglobinopathies Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Blood Transfusion

1.2.3 Iron Chelation Therapy

1.2.4 Bone Marrow Transplant

1.2.5 Others

1.3 Market by Application

1.3.1 Global Hemoglobinopathies Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Blood Testing

1.3.3 Genetic Testing

1.3.4 Pre-Implantation Genetic Diagnosis (PGD)

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Hemoglobinopathies Market Perspective (2019-2030)

2.2 Global Hemoglobinopathies Growth Trends by Region

2.2.1 Hemoglobinopathies Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Hemoglobinopathies Historic Market Size by Region (2019-2024)

2.2.3 Hemoglobinopathies Forecasted Market Size by Region (2025-2030)

2.3 Hemoglobinopathies Market Dynamics

2.3.1 Hemoglobinopathies Industry Trends

2.3.2 Hemoglobinopathies Market Drivers

2.3.3 Hemoglobinopathies Market Challenges

2.3.4 Hemoglobinopathies Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Hemoglobinopathies by Players

3.1.1 Global Hemoglobinopathies Revenue by Players (2019-2024)

3.1.2 Global Hemoglobinopathies Revenue Market Share by Players (2019-2024)

3.2 Global Hemoglobinopathies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Hemoglobinopathies, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Hemoglobinopathies Market Concentration Ratio

3.4.1 Global Hemoglobinopathies Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hemoglobinopathies Revenue in 2023

3.5 Global Key Players of Hemoglobinopathies Head office and Area Served

3.6 Global Key Players of Hemoglobinopathies, Product and Application

3.7 Global Key Players of Hemoglobinopathies, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Hemoglobinopathies Breakdown Data by Type

4.1 Global Hemoglobinopathies Historic Market Size by Type (2019-2024)

4.2 Global Hemoglobinopathies Forecasted Market Size by Type (2025-2030)

5 Hemoglobinopathies Breakdown Data by Application

5.1 Global Hemoglobinopathies Historic Market Size by Application (2019-2024)

5.2 Global Hemoglobinopathies Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Hemoglobinopathies Market Size (2019-2030)

6.2 North America Hemoglobinopathies Market Size by Type

6.2.1 North America Hemoglobinopathies Market Size by Type (2019-2024)

6.2.2 North America Hemoglobinopathies Market Size by Type (2025-2030)

6.2.3 North America Hemoglobinopathies Market Share by Type (2019-2030)

6.3 North America Hemoglobinopathies Market Size by Application

6.3.1 North America Hemoglobinopathies Market Size by Application (2019-2024)

6.3.2 North America Hemoglobinopathies Market Size by Application (2025-2030)

6.3.3 North America Hemoglobinopathies Market Share by Application (2019-2030)

6.4 North America Hemoglobinopathies Market Size by Country

6.4.1 North America Hemoglobinopathies Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Hemoglobinopathies Market Size by Country (2019-2024)

6.4.3 North America Hemoglobinopathies Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Hemoglobinopathies Market Size (2019-2030)

7.2 Europe Hemoglobinopathies Market Size by Type

7.2.1 Europe Hemoglobinopathies Market Size by Type (2019-2024)

7.2.2 Europe Hemoglobinopathies Market Size by Type (2025-2030)

7.2.3 Europe Hemoglobinopathies Market Share by Type (2019-2030)

7.3 Europe Hemoglobinopathies Market Size by Application

7.3.1 Europe Hemoglobinopathies Market Size by Application (2019-2024)

7.3.2 Europe Hemoglobinopathies Market Size by Application (2025-2030)

7.3.3 Europe Hemoglobinopathies Market Share by Application (2019-2030)

7.4 Europe Hemoglobinopathies Market Size by Country

7.4.1 Europe Hemoglobinopathies Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Hemoglobinopathies Market Size by Country (2019-2024)

7.4.3 Europe Hemoglobinopathies Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Hemoglobinopathies Market Size (2019-2030)

8.2 China Hemoglobinopathies Market Size by Type

8.2.1 China Hemoglobinopathies Market Size by Type (2019-2024)

8.2.2 China Hemoglobinopathies Market Size by Type (2025-2030)

8.2.3 China Hemoglobinopathies Market Share by Type (2019-2030)

8.3 China Hemoglobinopathies Market Size by Application

8.3.1 China Hemoglobinopathies Market Size by Application (2019-2024)

8.3.2 China Hemoglobinopathies Market Size by Application (2025-2030)

8.3.3 China Hemoglobinopathies Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Hemoglobinopathies Market Size (2019-2030)

9.2 Asia Hemoglobinopathies Market Size by Type

9.2.1 Asia Hemoglobinopathies Market Size by Type (2019-2024)

9.2.2 Asia Hemoglobinopathies Market Size by Type (2025-2030)

9.2.3 Asia Hemoglobinopathies Market Share by Type (2019-2030)

9.3 Asia Hemoglobinopathies Market Size by Application

9.3.1 Asia Hemoglobinopathies Market Size by Application (2019-2024)

9.3.2 Asia Hemoglobinopathies Market Size by Application (2025-2030)

9.3.3 Asia Hemoglobinopathies Market Share by Application (2019-2030)

9.4 Asia Hemoglobinopathies Market Size by Region

9.4.1 Asia Hemoglobinopathies Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Hemoglobinopathies Market Size by Region (2019-2024)

9.4.3 Asia Hemoglobinopathies Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Hemoglobinopathies Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Hemoglobinopathies Market Size by Type

10.2.1 Middle East, Africa, and Latin America Hemoglobinopathies Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Hemoglobinopathies Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Hemoglobinopathies Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Hemoglobinopathies Market Size by Application

10.3.1 Middle East, Africa, and Latin America Hemoglobinopathies Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Hemoglobinopathies Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Hemoglobinopathies Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Hemoglobinopathies Market Size by Country

10.4.1 Middle East, Africa, and Latin America Hemoglobinopathies Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Hemoglobinopathies Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Hemoglobinopathies Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Gamida Cell

11.1.1 Gamida Cell Company Details

11.1.2 Gamida Cell Business Overview

11.1.3 Gamida Cell Hemoglobinopathies Introduction

11.1.4 Gamida Cell Revenue in Hemoglobinopathies Business (2019-2024)

11.1.5 Gamida Cell Recent Developments

11.2 Alnylam Pharmaceuticals

11.2.1 Alnylam Pharmaceuticals Company Details

11.2.2 Alnylam Pharmaceuticals Business Overview

11.2.3 Alnylam Pharmaceuticals Hemoglobinopathies Introduction

11.2.4 Alnylam Pharmaceuticals Revenue in Hemoglobinopathies Business (2019-2024)

11.2.5 Alnylam Pharmaceuticals Recent Developments

11.3 Sanofi

11.3.1 Sanofi Company Details

11.3.2 Sanofi Business Overview

11.3.3 Sanofi Hemoglobinopathies Introduction

11.3.4 Sanofi Revenue in Hemoglobinopathies Business (2019-2024)

11.3.5 Sanofi Recent Developments

11.4 Sangamo Therapeutics Inc.

11.4.1 Sangamo Therapeutics Inc. Company Details

11.4.2 Sangamo Therapeutics Inc. Business Overview

11.4.3 Sangamo Therapeutics Inc. Hemoglobinopathies Introduction

11.4.4 Sangamo Therapeutics Inc. Revenue in Hemoglobinopathies Business (2019-2024)

11.4.5 Sangamo Therapeutics Inc. Recent Developments

11.5 Global Blood Therapeutics

11.5.1 Global Blood Therapeutics Company Details

11.5.2 Global Blood Therapeutics Business Overview

11.5.3 Global Blood Therapeutics Hemoglobinopathies Introduction

11.5.4 Global Blood Therapeutics Revenue in Hemoglobinopathies Business (2019-2024)

11.5.5 Global Blood Therapeutics Recent Developments

11.6 Bluebird Bio

11.6.1 Bluebird Bio Company Details

11.6.2 Bluebird Bio Business Overview

11.6.3 Bluebird Bio Hemoglobinopathies Introduction

11.6.4 Bluebird Bio Revenue in Hemoglobinopathies Business (2019-2024)

11.6.5 Bluebird Bio Recent Developments

11.7 Emmaus Life Sciences Inc.

11.7.1 Emmaus Life Sciences Inc. Company Details

11.7.2 Emmaus Life Sciences Inc. Business Overview

11.7.3 Emmaus Life Sciences Inc. Hemoglobinopathies Introduction

11.7.4 Emmaus Life Sciences Inc. Revenue in Hemoglobinopathies Business (2019-2024)

11.7.5 Emmaus Life Sciences Inc. Recent Developments

11.8 Prolong Pharmaceuticals

11.8.1 Prolong Pharmaceuticals Company Details

11.8.2 Prolong Pharmaceuticals Business Overview

11.8.3 Prolong Pharmaceuticals Hemoglobinopathies Introduction

11.8.4 Prolong Pharmaceuticals Revenue in Hemoglobinopathies Business (2019-2024)

11.8.5 Prolong Pharmaceuticals Recent Developments

11.9 Celgene Corporation

11.9.1 Celgene Corporation Company Details

11.9.2 Celgene Corporation Business Overview

11.9.3 Celgene Corporation Hemoglobinopathies Introduction

11.9.4 Celgene Corporation Revenue in Hemoglobinopathies Business (2019-2024)

11.9.5 Celgene Corporation Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Gamida Cell

Alnylam Pharmaceuticals

Sanofi

Sangamo Therapeutics, Inc.

Global Blood Therapeutics

Bluebird bio

Emmaus Life Sciences, Inc.

Prolong Pharmaceuticals

Celgene Corporation

List of Tables

Table 1. Global Hemoglobinopathies Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Blood Transfusion

Table 3. Key Players of Iron Chelation Therapy

Table 4. Key Players of Bone Marrow Transplant

Table 5. Key Players of Others

Table 6. Global Hemoglobinopathies Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Hemoglobinopathies Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Hemoglobinopathies Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Hemoglobinopathies Market Share by Region (2019-2024)

Table 10. Global Hemoglobinopathies Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Hemoglobinopathies Market Share by Region (2025-2030)

Table 12. Hemoglobinopathies Market Trends

Table 13. Hemoglobinopathies Market Drivers

Table 14. Hemoglobinopathies Market Challenges

Table 15. Hemoglobinopathies Market Restraints

Table 16. Global Hemoglobinopathies Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Hemoglobinopathies Revenue Share by Players (2019-2024)

Table 18. Global Top Hemoglobinopathies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoglobinopathies as of 2023)

Table 19. Global Hemoglobinopathies Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Hemoglobinopathies Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Hemoglobinopathies, Headquarters and Area Served

Table 22. Global Key Players of Hemoglobinopathies, Product and Application

Table 23. Global Key Players of Hemoglobinopathies, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Hemoglobinopathies Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Hemoglobinopathies Revenue Market Share by Type (2019-2024)

Table 27. Global Hemoglobinopathies Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Hemoglobinopathies Revenue Market Share by Type (2025-2030)

Table 29. Global Hemoglobinopathies Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Hemoglobinopathies Revenue Share by Application (2019-2024)

Table 31. Global Hemoglobinopathies Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Hemoglobinopathies Revenue Share by Application (2025-2030)

Table 33. North America Hemoglobinopathies Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Hemoglobinopathies Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Hemoglobinopathies Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Hemoglobinopathies Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Hemoglobinopathies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Hemoglobinopathies Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Hemoglobinopathies Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Hemoglobinopathies Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Hemoglobinopathies Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Hemoglobinopathies Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Hemoglobinopathies Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Hemoglobinopathies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Hemoglobinopathies Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Hemoglobinopathies Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Hemoglobinopathies Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Hemoglobinopathies Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Hemoglobinopathies Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Hemoglobinopathies Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Hemoglobinopathies Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Hemoglobinopathies Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Hemoglobinopathies Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Hemoglobinopathies Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Hemoglobinopathies Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Hemoglobinopathies Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Hemoglobinopathies Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Hemoglobinopathies Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Hemoglobinopathies Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Hemoglobinopathies Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Hemoglobinopathies Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Hemoglobinopathies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Hemoglobinopathies Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Hemoglobinopathies Market Size by Country (2025-2030) & (US$ Million)

Table 65. Gamida Cell Company Details

Table 66. Gamida Cell Business Overview

Table 67. Gamida Cell Hemoglobinopathies Product

Table 68. Gamida Cell Revenue in Hemoglobinopathies Business (2019-2024) & (US$ Million)

Table 69. Gamida Cell Recent Developments

Table 70. Alnylam Pharmaceuticals Company Details

Table 71. Alnylam Pharmaceuticals Business Overview

Table 72. Alnylam Pharmaceuticals Hemoglobinopathies Product

Table 73. Alnylam Pharmaceuticals Revenue in Hemoglobinopathies Business (2019-2024) & (US$ Million)

Table 74. Alnylam Pharmaceuticals Recent Developments

Table 75. Sanofi Company Details

Table 76. Sanofi Business Overview

Table 77. Sanofi Hemoglobinopathies Product

Table 78. Sanofi Revenue in Hemoglobinopathies Business (2019-2024) & (US$ Million)

Table 79. Sanofi Recent Developments

Table 80. Sangamo Therapeutics Inc. Company Details

Table 81. Sangamo Therapeutics Inc. Business Overview

Table 82. Sangamo Therapeutics Inc. Hemoglobinopathies Product

Table 83. Sangamo Therapeutics Inc. Revenue in Hemoglobinopathies Business (2019-2024) & (US$ Million)

Table 84. Sangamo Therapeutics Inc. Recent Developments

Table 85. Global Blood Therapeutics Company Details

Table 86. Global Blood Therapeutics Business Overview

Table 87. Global Blood Therapeutics Hemoglobinopathies Product

Table 88. Global Blood Therapeutics Revenue in Hemoglobinopathies Business (2019-2024) & (US$ Million)

Table 89. Global Blood Therapeutics Recent Developments

Table 90. Bluebird Bio Company Details

Table 91. Bluebird Bio Business Overview

Table 92. Bluebird Bio Hemoglobinopathies Product

Table 93. Bluebird Bio Revenue in Hemoglobinopathies Business (2019-2024) & (US$ Million)

Table 94. Bluebird Bio Recent Developments

Table 95. Emmaus Life Sciences Inc. Company Details

Table 96. Emmaus Life Sciences Inc. Business Overview

Table 97. Emmaus Life Sciences Inc. Hemoglobinopathies Product

Table 98. Emmaus Life Sciences Inc. Revenue in Hemoglobinopathies Business (2019-2024) & (US$ Million)

Table 99. Emmaus Life Sciences Inc. Recent Developments

Table 100. Prolong Pharmaceuticals Company Details

Table 101. Prolong Pharmaceuticals Business Overview

Table 102. Prolong Pharmaceuticals Hemoglobinopathies Product

Table 103. Prolong Pharmaceuticals Revenue in Hemoglobinopathies Business (2019-2024) & (US$ Million)

Table 104. Prolong Pharmaceuticals Recent Developments

Table 105. Celgene Corporation Company Details

Table 106. Celgene Corporation Business Overview

Table 107. Celgene Corporation Hemoglobinopathies Product

Table 108. Celgene Corporation Revenue in Hemoglobinopathies Business (2019-2024) & (US$ Million)

Table 109. Celgene Corporation Recent Developments

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Hemoglobinopathies Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Hemoglobinopathies Market Share by Type: 2023 VS 2030

Figure 3. Blood Transfusion Features

Figure 4. Iron Chelation Therapy Features

Figure 5. Bone Marrow Transplant Features

Figure 6. Others Features

Figure 7. Global Hemoglobinopathies Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Hemoglobinopathies Market Share by Application: 2023 VS 2030

Figure 9. Blood Testing Case Studies

Figure 10. Genetic Testing Case Studies

Figure 11. Pre-Implantation Genetic Diagnosis (PGD) Case Studies

Figure 12. Others Case Studies

Figure 13. Hemoglobinopathies Report Years Considered

Figure 14. Global Hemoglobinopathies Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Hemoglobinopathies Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Hemoglobinopathies Market Share by Region: 2023 VS 2030

Figure 17. Global Hemoglobinopathies Market Share by Players in 2023

Figure 18. Global Top Hemoglobinopathies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoglobinopathies as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Hemoglobinopathies Revenue in 2023

Figure 20. North America Hemoglobinopathies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Hemoglobinopathies Market Share by Type (2019-2030)

Figure 22. North America Hemoglobinopathies Market Share by Application (2019-2030)

Figure 23. North America Hemoglobinopathies Market Share by Country (2019-2030)

Figure 24. United States Hemoglobinopathies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Hemoglobinopathies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Hemoglobinopathies Market Size YoY (2019-2030) & (US$ Million)

Figure 27. Europe Hemoglobinopathies Market Share by Type (2019-2030)

Figure 28. Europe Hemoglobinopathies Market Share by Application (2019-2030)

Figure 29. Europe Hemoglobinopathies Market Share by Country (2019-2030)

Figure 30. Germany Hemoglobinopathies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Hemoglobinopathies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Hemoglobinopathies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Hemoglobinopathies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Hemoglobinopathies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Hemoglobinopathies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. China Hemoglobinopathies Market Size YoY (2019-2030) & (US$ Million)

Figure 37. China Hemoglobinopathies Market Share by Type (2019-2030)

Figure 38. China Hemoglobinopathies Market Share by Application (2019-2030)

Figure 39. Asia Hemoglobinopathies Market Size YoY (2019-2030) & (US$ Million)

Figure 40. Asia Hemoglobinopathies Market Share by Type (2019-2030)

Figure 41. Asia Hemoglobinopathies Market Share by Application (2019-2030)

Figure 42. Asia Hemoglobinopathies Market Share by Region (2019-2030)

Figure 43. Japan Hemoglobinopathies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. South Korea Hemoglobinopathies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. China Taiwan Hemoglobinopathies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Hemoglobinopathies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. India Hemoglobinopathies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Australia Hemoglobinopathies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Hemoglobinopathies Market Size YoY (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Hemoglobinopathies Market Share by Type (2019-2030)

Figure 51. Middle East, Africa, and Latin America Hemoglobinopathies Market Share by Application (2019-2030)

Figure 52. Middle East, Africa, and Latin America Hemoglobinopathies Market Share by Country (2019-2030)

Figure 53. Brazil Hemoglobinopathies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Mexico Hemoglobinopathies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Turkey Hemoglobinopathies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Hemoglobinopathies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Israel Hemoglobinopathies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. GCC Countries Hemoglobinopathies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Gamida Cell Revenue Growth Rate in Hemoglobinopathies Business (2019-2024)

Figure 60. Alnylam Pharmaceuticals Revenue Growth Rate in Hemoglobinopathies Business (2019-2024)

Figure 61. Sanofi Revenue Growth Rate in Hemoglobinopathies Business (2019-2024)

Figure 62. Sangamo Therapeutics Inc. Revenue Growth Rate in Hemoglobinopathies Business (2019-2024)

Figure 63. Global Blood Therapeutics Revenue Growth Rate in Hemoglobinopathies Business (2019-2024)

Figure 64. Bluebird Bio Revenue Growth Rate in Hemoglobinopathies Business (2019-2024)

Figure 65. Emmaus Life Sciences Inc. Revenue Growth Rate in Hemoglobinopathies Business (2019-2024)

Figure 66. Prolong Pharmaceuticals Revenue Growth Rate in Hemoglobinopathies Business (2019-2024)

Figure 67. Celgene Corporation Revenue Growth Rate in Hemoglobinopathies Business (2019-2024)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Hemoglobinopathy Treatment Market Insights Forecast to 2030

Global Hemoglobinopathy Testing Services Market Insights Forecast to 2030

Thalassemia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hemoglobinometers Market Insights Forecast to 2030

Global Hemoglobinopathies Drugs Market Research Report 2024

Global Thalassemia Treatment Market Research Report 2025

Global Rare Hematology Treatment Market Insights Forecast to 2030

Global Anemia Treatment Drugs Market Insights Forecast to 2030

Alpha Thalassemia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Alpha Thalassemia Treatment Market Insights Forecast to 2030

Sickle cell Anemia Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sickle Cell Disease Diagnosis Market Insights Forecast to 2030

Global Hemoglobin Meter Market Insights Forecast to 2030

Hemoglobinopathy Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Adult Hemoglobinopathy Testing Market Insights Forecast to 2030

Global Cryoglobulinemia Treatment Market Research Report 2025

Global Blood Cancer Therapeutics Market Insights Forecast to 2030

Global Hemoglobin Screening Systems Market Research Report 2024

Hemoglobin Testing Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions